... Home Contact us Press Room Aurobindo's Q1 Net Profit up by 61.7 %Approval received from US FDA for Amlodipine Besylate Tablets Received 46th ANDA approval from US FDA for Terbinafine HCL Tablets Aurobindo records revenues of Rs.23 billions with multifold growth in earnings Aurobindo receives Tentative approval for Quinapril Hydrochloride and Hydrochlorothiazide Tablets from USFDA Aurobindo received Zidovudine approval from MCC South Africa Aurobindo gets USFDA Approval for Trandolapril Tablets Aurobindo receives USFDA Approval for Cefpodoxime proxetil Tablets Aurobindo Pharma Unveils New Corporate Identity Aurobindo receives USFDA Approval for its Ciprofloxacin Aurobindo gets USFDA Approval for its Cefprozil Tablets Aurobindo receives USFDA Approval for its Zolpidem Aurobindo receives ninth approval from MCC South Africa Aurobindo receives Eighth approval from MCC South Africa MEB Netherlands approves Lisinopril Tablets of Aurobindo Cephazone, cephalosporin sterile injectable facility in California, is approved by US FDA and receives approval of Ceftriaxone from US FDA Aurobindo receives US FDA Final approval For Didanosine Oral Suspension Aurobindo receives NAM Finland Approval for its facility at UNIT-VI Aurobindo ’ s debut in Botswana is with 9 products in one go Seventh approval from MCC South Africa Aurobindo ’ s tally of USFDA approved cephs ...